Jiangsu Meitong Pharmaceutical

Jiangsu Meitong Pharmaceutical is a biopharmaceutical company based in Taizhou, China, specializing in the discovery and development of innovative small molecule drugs. The company focuses on therapeutic areas with significant unmet medical needs, including oncology, cardiovascular diseases, and metabolic disorders. Operating out of the China Medical City (CMC), Meitong integrates a comprehensive R&D infrastructure with large-scale GMP-compliant manufacturing facilities. Their pipeline features several proprietary candidates, most notably programs targeting cancer-related cachexia and advanced solid tumors. The company aims to bridge the gap between laboratory innovation and commercial-scale production to serve both domestic and international markets.